Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982

Online
ISSN
1437-4331
See all formats and pricing
In This Section
Volume 41, Issue 10 (Sep 2003)

Issues

The New European Directive on in vitro Diagnostics

Francesco Dati
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2003.196

Abstract

The Directive on in vitro Diagnostic Medical Devices (IVDD 98/79/EC) was officially adopted by the European Union (EU) on December 7, 1998. The IVDD aims to supplement the legal framework of the European Community, which governs the conditions for the placing on the market of medical devices, by extending the already implemented legislation to the category of in vitro diagnostic medical devices (IVDs). They consist of those devices, including reagents and reagent products, calibrator materials or instruments, as well as specimen receptacles, intended by the manufacturer for the in vitro analysis of specimens derived from the human body. This directive has introduced at the European level common regulatory requirements across Europe for the safety, quality and performance of in vitro diagnostics (IVDs), incorporating them into medical device legislation. It harmonizes the conformity assessment procedures to be applied by manufacturers before they place IVDs on the market. For certain products expressly specified in the directive, of which the most important are used for the evaluation of the safety of blood supply and patient testing, the manufacturer will have to take into account in their performance evaluation the so-called "Common Technical Specifications" (CTS). These are needed to establish the performance characteristics of the IVDs in evaluation and have the same status as harmonized standards. In the meantime, the IVD directive has been transposed into national law in all EU countries. During a transitional period ending in December 2003, manufacturers will have the option of following pre-existing national regulatory processes or taking their IVDs through the new procedures as specified in the directive. Following this, starting from 7th December 2003, adherence to the directive regulations will become mandatory, and only IVDs bearing the "Communautés Européennes (CE) mark" can then be sold in the EU. Clin Chem Lab Med 2003; 41(10): 12891298

About the article

Published Online: 2005-06-01

Published in Print: 2003-09-19



Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2003.196. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Henrik Winther and Jan Trøst Jørgensen
Pharmaceutical Medicine, 2010, Volume 24, Number 6, Page 363
[2]
M. Schmidt, A. Jimenez, A. Mühlbacher, S. Oota, L. Blanco, T. Sakuldamrongpanich, H. Schennach, and E. Seifried
Vox Sanguinis, 2015, Page n/a
[3]
[4]
Anna Carobene, Ferruccio Ceriotti, Ilenia Infusino, Erika Frusciante, and Mauro Panteghini
Clinica Chimica Acta, 2014, Volume 427, Page 100
[5]
Ilenia Infusino and Mauro Panteghini
Clinica Chimica Acta, 2013, Volume 419, Page 15
[6]
K. M. Palamountain, J. Baker, E. P. Cowan, S. Essajee, L. T. Mazzola, M. Metzler, M. Schito, W. S. Stevens, G. J. Young, and G. J. Domingo
Journal of Infectious Diseases, 2012, Volume 205, Number suppl 2, Page S181
[7]
Uwe Christians, Jacek Klepacki, Touraj Shokati, Jost Klawitter, and Jelena Klawitter
Microchemical Journal, 2012, Volume 105, Page 32
[8]
Elvar Theodorsson
Bioanalysis, 2012, Volume 4, Number 3, Page 305
[10]
Mauro Panteghini
Clinical Chemistry and Laboratory Medicine, 2012, Volume 50, Number 7
[11]
Rob Jansen, Gerhard Schumann, Henk Baadenhuijsen, Paul Franck, Carlo Franzini, Rolf Kruse, Aldy Kuypers, Cas Weykamp, and Mauro Panteghini
Clinica Chimica Acta, 2006, Volume 368, Number 1-2, Page 160
[13]
Emmanuel J. Favaloro, Mario Plebani, and Giuseppe Lippi
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 12
[14]
Joris R. Delanghe, Christa Cobbaert, Aimo Harmoinen, Rob Jansen, Päivi Laitinen, and Mauro Panteghini
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 6
[15]
Anne Marie Dupuy, Sylvain Lehmann, and Jean Paul Cristol
Clinical Chemical Laboratory Medicine, 2005, Volume 43, Number 12
[16]
[17]
Stephen M Henry
Current Opinion in Hematology, 2009, Volume 16, Number 6, Page 467
[18]
Susanne Listl and Mariam Klouche
Transfusion Medicine and Hemotherapy, 2006, Volume 33, Number 5, Page 374
[19]
Nader Rifai, Michael A Gillette, and Steven A Carr
Nature Biotechnology, 2006, Volume 24, Number 8, Page 971

Comments (0)

Please log in or register to comment.
Log in